Joel N Blankson

Associate Professor

1992 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
HIV-1 Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Viral Load Medicine & Life Sciences
Human immunodeficiency virus 1 Agriculture & Biology
HIV Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Viremia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2018

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses

Pohlmeyer, C. W., Laskey, S. B., Beck, S. E., Xu, D. C., Capoferri, A. A., Garliss, C. C., May, M. E., Livingston, A., Lichmira, W., Moore, R. D., Sue Leffell, M., Butler, N. J., Thorne, J. E., Flynn, J. A., Siliciano, R. F. & Blankson, J. N. Feb 1 2018 In : PLoS ONE. 13, 2, e0192098

Research output: Contribution to journalArticle

T-cells
Human immunodeficiency virus 1
HIV-1
T-lymphocytes
HIV

Characterization of elite suppressors cell-associated HIV-1 mRNA at baseline and with T cell activation

Pohlmyer, C. W., Bullen, C. K., Martin, A. R., Laird, G. M., Chioma, S. U., Walker-Sperling, V. E. K. & Blankson, J. N. Jun 1 2017 In : Yale Journal of Biology and Medicine. 90, 2, p. 331-336 6 p.

Research output: Contribution to journalArticle

T-cells
HIV-1
Chemical activation
T-Lymphocytes
Messenger RNA

Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities

Aberg, J. A., Blankson, J., Marrazzo, J. & Adimora, A. A. 2017 In : Journal of Infectious Diseases. 216, p. S606-S610

Research output: Contribution to journalArticle

Salaries and Fringe Benefits
Communicable Diseases
Physicians
Minority Groups
Qualitative Research

HIV-1 persistence following extre277277mely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

Henrich, T. J. , Hatano, H. , Bacon, O. , Hogan, L. E. , Rutishauser, R. , Hill, A. , Kearney, M. F. , Anderson, E. M. , Buchbinder, S. P. , Cohen, S. E. , Abdel-Mohsen, M. , Pohlmeyer, C. W. , Fromentin, R. , Hoh, R. , Liu, A. Y. , McCune, J. M. , Spindler, J. , Metcalf-Pate, K. , Hobbs, K. S. , Thanh, C. & 12 others Gibson, E. A., Kuritzkes, D. R., Siliciano, R. F., Price, R. W., Richman, D. D., Chomont, N., Siliciano, J. D., Mellors, J. W., Yukl, S. A., Blankson, J. N., Liegler, T. & Deeks, S. G. Nov 1 2017 In : PLoS medicine. 14, 11, e1002417

Research output: Contribution to journalArticle

Anti-Retroviral Agents
Secondary Prevention
HIV Infections
Observational Studies
HIV-1

HIV-1 reservoirs in elite controllers: Clues for developing a functional cure?

May, M. E., Kwaa, A. K. & Blankson, J. N. Sep 1 2017 In : Future Microbiology. 12, 12, p. 1019-1022 4 p.

Research output: Contribution to journalReview article

Antiviral Agents
HIV-1
Immunity